KP Tissue financials at a glance
Year | Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M |
GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | Earnings Per Share |
|
C$0.72 | C$-0.03 | C$2.71 | C$-0.57 | C$3.86 | C$0.26 | C$0.08 | C$0.29 | C$1.04 | C$0.07 | C$-8.82 | C$-1.01 | C$0.00 |
Div. | Dividends |
|
C$0.15 | C$0.72 | C$0.72 | C$0.72 | C$0.72 | C$0.72 | C$0.72 | C$0.72 | C$0.72 | C$0.72 | C$0.72 | C$0.72 | C$0.00 |
PR % | Payout Ratio % |
|
20.83% | -2400.00% | 26.57% | -126.32% | 18.65% | 276.92% | 900.00% | 248.28% | 69.23% | 1028.57% | -8.16% | -71.29% | 0 |
Sha. | Shares |
|
8m | 8.79m | 8.86m | 8.96m | 9.09m | 9.21m | 9.41m | 9.63m | 9.75m | 9.9m | 9.9m | 0m | 9.96m |
OCF | Operating Cash Flow |
|
C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M |
FCF | Free Cash Flow |
|
C$0.00M | C$-4.44M | C$51.87M | C$26.65M | C$60.19M | C$31.10M | C$63.98M | C$-41.40M | C$-41.40M | C$0.00M | C$-76.90M | C$1.45M | C$0.00M |
FCFS | Free Cash Flow Per Share |
|
C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 |